Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| IND# 79,632 | |||
| 5R01DA016776 | U.S. NIH Grant/Contract | View source | |
| CHR# H6637-31759-01 | |||
| IRB# 27.112 | |||
| RAP-C# 0740 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
| University of California, San Francisco | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MDA | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MDA | Drug | subjects will receive a single oral dose of MDA 98mg/70kg body weight |
| |
| Measure | Description | Time Frame |
|---|---|---|
| MDA will be metabolized to hydroxyamphetamine (HMA) and dihydroxyamphetamine (DHA) and will produce dose-dependent increases in neuroendocrine measures. | 0-48 hours post dose |
| Measure | Description | Time Frame |
|---|---|---|
| MDA will produce dose-dependent increases in self-report entactogen-like and stimulant like measures. | 0-48 hours post dose |
Not provided
Inclusion Criteria:
Exclusion Criteria:
FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John E Mendelson, MD | CPMC Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CPMC Addiction & Pharmacology Research Laboratory (APRL) | San Francisco | California | 94110 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21152030 | Result | Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE. Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. PLoS One. 2010 Dec 2;5(12):e14074. doi: 10.1371/journal.pone.0014074. |
| Label | URL |
|---|---|
| Addiction \& Pharmacology Research Laboratory webpage | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo |
| Drug |
Subjects will receive a single oral dose of placebo |
|
| PLoS ONE | View source |